Lataa...
Temozolomide resistance in glioblastoma multiforme
Temozolomide (TMZ) is an oral alkylating agent used to treat glioblastoma multiforme (GBM) and astrocytomas. However, at least 50% of TMZ treated patients do not respond to TMZ. This is due primarily to the over-expression of O(6)-methylguanine methyltransferase (MGMT) and/or lack of a DNA repair pa...
Tallennettuna:
| Julkaisussa: | Genes Dis |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Chongqing Medical University
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6150109/ https://ncbi.nlm.nih.gov/pubmed/30258889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gendis.2016.04.007 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|